Specific Enhancement of Vascular Endothelial Growth Factor (VEGF) Production in Ischemic Region by Alprostadil - Potential Therapeutic Application in Pharmaceutical Regenerative Medicine
Alprostadil (lipo-PGE1) is a drug delivery system preparation. This preparation is applied to treat refractory skin ulcers and arteriosclerosis obliterans. We investigated the effects of alprostadil by using the earflap ischemic model. The following results were obtained: 1) Treatment with alprostad...
Saved in:
Main Authors: | Hajime Inoue (Author), Masaki Aihara (Author), Miyuki Tomioka (Author), Yu-ichi Watabe (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in Health and Disease
by: Sylvain Broussy
Published: (2024) -
The Effect of Resistance Training on Vascular Endothelial Growth Factor (VEGF) in Older Women
by: Alireza Behjati, et al.
Published: (2015) -
Serum Vascular Endothelial Growth Factor (VEGF) in DMPA Acceptors: Influence on Bleeding Occurrence
by: Ratih Pratiwi, et al.
Published: (2015) -
The Effect and Mechanism of Vascular Endothelial Growth Factor (VEGF) on Tumor Angiogenesis in Gallbladder Carcinoma
by: Dongqing XU, et al.
Published: (2019) -
The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
by: Yue Zhao, et al.
Published: (2018)